News

Exploring the Recent Options Trends for DraftKings Stock

Exploring the Recent Options Trends for DraftKings Stock

Understanding DraftKings Options Activity

Recent data indicates a strong bullish sentiment among investors for DraftKings. This surge in activity on options shows that significant players in the market are optimistic about the company's potential.

In examining the options history for DraftKings (NASDAQ: DKNG), we uncovered a total of 22 trades. Analyzing these trades reveals that 54% were executed with bullish expectations while 27% expressed a bearish outlook.

Out of the total trades, we identified that there were 13 put options amounting to $825,931 and 9 call options totaling $452,734. This highlights the varied strategies investors are employing regarding DraftKings.

Projected Price Range for DraftKings

Based on the volume and open interest surrounding these contracts, it appears that major investors expect DraftKings shares to target a price range between $20.0 and $52.5 over the past three months.

Current Volume and Open Interest Analysis

In terms of options liquidity, today's average open interest for DraftKings options trades is 749.25 with a total trading volume reaching 8,438.00. This represents significant engagement from the market.

DraftKings Options Activity: Last Month Breakdown

Studying the flow of options provides invaluable insight into investor sentiment and market trends. The most notable options for DraftKings during the last month suggest a keen interest around exit strategies and potential profit realizations.

Examining Key Options Trades

The following trades illustrate the interest around DraftKings:

  • PUT Option: A trade with an expiration date in August 2025 shows notable bullish sentiment.
  • PUT Option: Another trade set for September 2025 highlights the continued confidence among traders.
  • CALL Options: Other transactions include both bullish and bearish stances, with examples extending into 2025.

About DraftKings

Since its inception in 2012, DraftKings has positioned itself as a pioneer in daily fantasy sports. After a landmark Supreme Court ruling in 2018 permitted online sports wagering, DraftKings broadened its scope to include online sports and casino gambling. At present, the company maintains a competitive edge, often ranking second or third in terms of market share in the states it operates.

DraftKings currently engages in online and retail sports betting across about 25 states and offers iGaming in five states, reaching approximately 40% of Canada's population. In recent reports, the company's sales indicated that sports revenue comprised 61% of total sales, while iGaming represented 32% and fantasy and lottery activities accounted for 7%.

Recently, DraftKings launched a marketplace for non-fungible tokens (NFTs), further diversifying its offerings within the digital and gaming space.

DraftKings Market Position Today

  • The current volume for DraftKings stands at 7,662,814, with shares priced at $36.86, a drop of 6.47% from previous levels.
  • Relative Strength Indicators (RSIs) suggest that the stock may be heading toward an oversold condition.
  • The company expects to announce its next earnings report in approximately 52 days.

Insights from Industry Analysts

Recent evaluations by five industry analysts have yielded a consensus target price for DraftKings at $57.00, reflecting a strong belief in the stock's potential growth.

Several analysts have maintained a positive outlook:

  • Benchmark has reiterated its Buy rating with a price target of $51.
  • Morgan Stanley continues to uphold its Overweight rating with a target set at $53.
  • JP Morgan has also kept its Overweight rating while targeting a price of $61.
  • Wells Fargo maintains an Overweight rating with a price target of $60.
  • JMP Securities retains a Market Outperform rating, also with a price target of $60.

Investing in options can present numerous risks but can lead to considerable profits when managed effectively. Investors are advised to keep abreast of market dynamics, engage in continual education, and strategically manage trades as market conditions shift.

Frequently Asked Questions

What is the recent options activity for DraftKings?

DraftKings has seen a recent surge in options trading, indicating increased bullish sentiment among investors.

What is the average target price for DraftKings shares?

The average target price proposed by analysts for DraftKings is around $57.00.

How do analysts rate DraftKings stock?

Various analysts maintain positive ratings, with several estimating price targets between $51 and $61.

What sectors does DraftKings operate in?

DraftKings primarily operates in online sports betting and casino gaming, alongside daily fantasy sports and NFTs.

When is DraftKings expected to release its next earnings report?

The company is projected to announce its next earnings report in about 52 days.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 545

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 791

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 526

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 112

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 129

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 188

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 190

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 138

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 40

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 309

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

Volvo Ends LiDAR Partnership: What This Means for LAZR Stock

Updated Category News Views 315

Volvo's Shift Away from LiDAR Technology Recently, the Swedish automaker Volvo announced its decision to cease its partnership with Luminar Technologies Inc. (NASDAQ: LAZR). This bold move has caught the attention of the automotive industry, especially those tracking advancements in autonomous vehicle technology. By not integrating LiDAR technology into its forthcoming...

Continue Reading
Samsung and Xiaomi Face Antitrust Findings in India Market

Updated Category News Views 157

Samsung and Xiaomi Face Antitrust Investigation in India Samsung, Xiaomi, and various other smartphone manufacturers are under serious scrutiny for allegedly colluding with major e-commerce platforms in India, undermining fair market practices. The Competition Commission of India (CCI) has gathered evidence that suggests these companies coordinated with Amazon and...

Continue Reading
Bonnie Navin Honored as Top 25 Medical Malpractice Attorney

Updated Category News Views 164

Bonnie Navin Attributes and Accolades Bonnie Navin of Rubenstein Law has recently earned a significant honor by being selected as a member of the Medical Malpractice Trial Lawyers Association - Top 25. This elite recognition is awarded to the most distinguished attorneys specializing in medical malpractice across the nation, and it showcases Navin's exceptional skill and...

Continue Reading
Top Dividend Stocks for Long-Term Passive Income Investors

Updated Category News Views 99

Success in the business world has never been a cakewalk. Many new ventures stumble within a decade, and only a handful manage to stay afloat while also boasting a robust and growing dividend program. Companies that consistently dish out dividends reflect financial health, but there’s more to the story. Take Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE:...

Continue Reading
Cathie Wood Predicts Deflationary Boom Amid Market Decline

Updated Category News Views 404

Cathie Wood's Deflationary Boom Forecast Amid Market Turbulence CEO of Ark Funds, Cathie Wood, has made bold predictions regarding a potential "deflationary boom" despite significant losses in the stock market. Recent trading sessions saw renowned tech stocks, collectively known as the Magnificent Seven, lose about $780 billion in market capitalization in a single day,...

Continue Reading